4DMedical Ltd
ASX:4DX

Watchlist Manager
4DMedical Ltd Logo
4DMedical Ltd
ASX:4DX
Watchlist
Price: 0.455 AUD 1.11% Market Closed
Market Cap: 186.8m AUD
Have any thoughts about
4DMedical Ltd?
Write Note

Intrinsic Value

4DX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one 4DX stock under the Base Case scenario is 0.444 AUD. Compared to the current market price of 0.455 AUD, 4DMedical Ltd is Overvalued by 2%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

4DX Intrinsic Value
0.444 AUD
Overvaluation 2%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
4DMedical Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for 4DX cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about 4DX?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about 4DMedical Ltd

Provide an overview of the primary business activities
of 4DMedical Ltd.

What unique competitive advantages
does 4DMedical Ltd hold over its rivals?

What risks and challenges
does 4DMedical Ltd face in the near future?

Has there been any significant insider trading activity
in 4DMedical Ltd recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for 4DMedical Ltd.

Provide P/S
for 4DMedical Ltd.

Provide P/E
for 4DMedical Ltd.

Provide P/OCF
for 4DMedical Ltd.

Provide P/FCFE
for 4DMedical Ltd.

Provide P/B
for 4DMedical Ltd.

Provide EV/S
for 4DMedical Ltd.

Provide EV/GP
for 4DMedical Ltd.

Provide EV/EBITDA
for 4DMedical Ltd.

Provide EV/EBIT
for 4DMedical Ltd.

Provide EV/OCF
for 4DMedical Ltd.

Provide EV/FCFF
for 4DMedical Ltd.

Provide EV/IC
for 4DMedical Ltd.

Show me price targets
for 4DMedical Ltd made by professional analysts.

What are the Revenue projections
for 4DMedical Ltd?

How accurate were the past Revenue estimates
for 4DMedical Ltd?

What are the Net Income projections
for 4DMedical Ltd?

How accurate were the past Net Income estimates
for 4DMedical Ltd?

What are the EPS projections
for 4DMedical Ltd?

How accurate were the past EPS estimates
for 4DMedical Ltd?

What are the EBIT projections
for 4DMedical Ltd?

How accurate were the past EBIT estimates
for 4DMedical Ltd?

Compare the revenue forecasts
for 4DMedical Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of 4DMedical Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of 4DMedical Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of 4DMedical Ltd compared to its peers.

Compare the P/E ratios
of 4DMedical Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing 4DMedical Ltd with its peers.

Analyze the financial leverage
of 4DMedical Ltd compared to its main competitors.

Show all profitability ratios
for 4DMedical Ltd.

Provide ROE
for 4DMedical Ltd.

Provide ROA
for 4DMedical Ltd.

Provide ROIC
for 4DMedical Ltd.

Provide ROCE
for 4DMedical Ltd.

Provide Gross Margin
for 4DMedical Ltd.

Provide Operating Margin
for 4DMedical Ltd.

Provide Net Margin
for 4DMedical Ltd.

Provide FCF Margin
for 4DMedical Ltd.

Show all solvency ratios
for 4DMedical Ltd.

Provide D/E Ratio
for 4DMedical Ltd.

Provide D/A Ratio
for 4DMedical Ltd.

Provide Interest Coverage Ratio
for 4DMedical Ltd.

Provide Altman Z-Score Ratio
for 4DMedical Ltd.

Provide Quick Ratio
for 4DMedical Ltd.

Provide Current Ratio
for 4DMedical Ltd.

Provide Cash Ratio
for 4DMedical Ltd.

What is the historical Revenue growth
over the last 5 years for 4DMedical Ltd?

What is the historical Net Income growth
over the last 5 years for 4DMedical Ltd?

What is the current Free Cash Flow
of 4DMedical Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for 4DMedical Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
4DMedical Ltd

Current Assets 39.1m
Cash & Short-Term Investments 30.6m
Receivables 5.9m
Other Current Assets 2.6m
Non-Current Assets 81m
PP&E 8.7m
Intangibles 72.2m
Other Non-Current Assets 44.8k
Current Liabilities 21.9m
Accounts Payable 5.1m
Accrued Liabilities 1.8m
Other Current Liabilities 15m
Non-Current Liabilities 27.2m
Long-Term Debt 4.2m
Other Non-Current Liabilities 23m
Efficiency

Earnings Waterfall
4DMedical Ltd

Revenue
3.8m AUD
Cost of Revenue
-236.7k AUD
Gross Profit
3.5m AUD
Operating Expenses
-38.4m AUD
Operating Income
-34.9m AUD
Other Expenses
-1m AUD
Net Income
-36m AUD

Free Cash Flow Analysis
4DMedical Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

4DX Profitability Score
Profitability Due Diligence

4DMedical Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
37/100
Profitability
Score

4DMedical Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

4DX Solvency Score
Solvency Due Diligence

4DMedical Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Negative Net Debt
Low D/E
Long-Term Solvency
70/100
Solvency
Score

4DMedical Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

4DX Price Targets Summary
4DMedical Ltd

Wall Street analysts forecast 4DX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 4DX is 0.918 AUD with a low forecast of 0.758 AUD and a high forecast of 1.155 AUD.

Lowest
Price Target
0.758 AUD
66% Upside
Average
Price Target
0.918 AUD
102% Upside
Highest
Price Target
1.155 AUD
154% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for 4DX?

Click here to dive deeper.

Dividends

4DMedical Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for 4DX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

4DX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

4DMedical Ltd Logo
4DMedical Ltd

Country

Australia

Industry

Health Care

Market Cap

186.7m AUD

Dividend Yield

0%

Description

4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-08-07. The firm is focused on development of a non-invasive respiratory imaging solution using four-dimensional imaging. The firm's XV Technology is a four-dimensional lung imaging technology that utilizes mathematical models and algorithms to convert X-ray scans into quantitative data for physicians to manage patients with respiratory diseases and diseases of the lung. The XV Technology is accessible through a cloud-based software as a service (SaaS) platform that integrates with existing hospital equipment. The XV Technology Lung Ventilation Analysis Software (XV LVAS Ventilation) provides a non-invasive way of understanding regional lung motion and airflow. The company enables physicians to detect areas of high and low ventilation from all parts of the lung, in all phases of the breath.

Contact

VICTORIA
Melbourne
5/468 St. Kilda Road
+61395455940.0
4dmedical.com

IPO

2020-08-07

Employees

-

Officers

Founder, MD, CEO & Director
Dr. Andreas Fouras M.A.I.C.D., Ph.D.
Chief Financial Officer
Mr. Simon Glover
Strategic Advisor & Executive Director
Mr. John Andrew Livingston BAppSci, GradCertBus, GradDipHSc
Chief Commercial Officer
Mr. Matt Tucker
Company Secretary & General Counsel
Ms. Naomi Lawrie
Senior Vice President of Engineering
Dr. Aidan Jamison B.E., Ph.D.
Show More
Senior Vice President of Product
Ms. Rachael Tenkaten
Chief Medical Officer
Dr. Greg T. Mogel M.D.
Senior Vice President of Global Business Development
Mr. David Hannes B.S., M.B.A.
Show Less

See Also

Discover More
What is the Intrinsic Value of one 4DX stock?

The intrinsic value of one 4DX stock under the Base Case scenario is 0.444 AUD.

Is 4DX stock undervalued or overvalued?

Compared to the current market price of 0.455 AUD, 4DMedical Ltd is Overvalued by 2%.

Back to Top